Nutraceutical ingredient start-up Zeus Hygia raises $2.5 M

Zeus Hygia aims to accelerate the development of advanced products and solutions by leveraging top-notch research and technology

Zeus Hygia, a science-led nutraceutical ingredient manufacturer, has successfully raised $2.5 million in Series A funding from NABVENTURES, the venture capital arm of NABARD. This growth capital will fuel the company’s next phase of innovation and international expansion.

Founded by Dr Arunkanth Krishnakumar and Shankaranarayanan Jeyakodi, the company is on a mission to provide safe, effective, and evidence-backed herbal extracts to the wellness industry. Zeus’s portfolio currently includes eight branded, clinically backed ingredients i.e. BioSOLVE Curcumin, CaroTex, Grantria, GreMin, Stadice, Gevalin, Metaberine and Consolax, with several more in the pipeline.

With the new funding, Zeus Hygia aims to accelerate the development of advanced products and solutions by leveraging top-notch research and technology. Responding to growing global demand, the company is actively formulating several first-in-market ingredients focused on pain management, weight management, performance enhancement, women’s health and healthy ageing.

“We’re at an exciting inflection point in our journey,” said Dr Arunkanth Krishnakumar, Co-founder and CEO, Zeus Hygia. “This funding from NABVENTURES validates our scientific approach and gives us the momentum to bring innovative, clinically backed nutraceutical solutions to a global audience. Our goal is to set new benchmarks for quality and efficacy in the wellness industry.”

Ankita Bhatnagar, Vice President, NABVENTURES said “Zeus Hygia’s innovative approach to developing high-value nutraceutical ingredients from India-based plant products is a game-changer. This not only unlocks significant potential for our farmers to cultivate crops with enhanced economic returns but also addresses the global demand for natural ingredients. Zeus Hygia stands out with its commitment to clinically validated, patented, plant-based solutions, positioning India at the forefront of the global nutraceutical landscape and fostering a vibrant ecosystem of agricultural prosperity and global well-being.”

The company already exports to over 15 countries and has established a unit in the US to strengthen its foothold in North America. It is also actively expanding into Southeast Asia, with further focus on the APAC and MENA regions.

Over the next three years, Zeus Hygia aims to scale its international presence through direct operations and strategic partnerships, expecting nearly 70 per cent of its revenue to come from global markets. The company has recently collaborated with some of the leading Japanese and Korean nutraceutical and FMCG companies on joint venture development projects, which are expected to be commercially launched within the next two years.